Overview of the Management of COVID-19 Efficacy and Doubts
O. A. Ayodeji, C. N. Stanley, P. C. Stanley
Journal of Advances in Medicine and Medical Research · pp. 47–53 · Published 25 May 2020
10.9734/jammr/2020/v32i730449Abstract
Coronavirus disease 2019 (COVID-19) is defined as an illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2. It was first identified during an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China. Management of COVID-19 is still unspecific as there are no vaccine or specific antiviral drugs are available for its treatment. This paper reviews the management efficacy and doubt of COVID-19. Methods: A comprehensive search from relevant literatures, World Health Organization (W.H.O), Centre for Disease Control and prevention (CDC) official websites and announcements was performed between 1 March 2020 to 10:30 am 22 April 2020 (Nigerian time). A latest summary of 2019- nCoV and the current outbreak was drawn. Conclusion: The covid-19 pandemic is spreading rapidly and several researchers are making efforts to discover drugs for its treatment. Chloroquine phosphate, vaccines and other forms of management strategies have been employed. However, preventive measures like social distancing, washing of hands with soap and water, wearing of face masks and psychosocial treatment should be adopted while waiting for pharmacological treatments.
Cited by 2
2 citations reported by external sources — individual citing-article records aren't available to list yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID-19 Pandemic - Clinical Features, Recent Investigations, Diagnosis, Modes of Transmission, and Role of WHO — shares topic coverage
- Dentistry during the COVID-19 Era: Safety Protocols and Considerations — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
2
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.